The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early Alzheimer’s, making it the second therapy for slowing progression of the brain-wasting disease that will be …
New Delhi: A top panel under the Central Drugs Standard Control Organisation (CDSCO) — India’s national regulatory body for pharmaceuticals and medical devices — has recommended regulatory approval to import …
The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease and will hold a meeting of outside experts to discuss …
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly’s Zepbound, …
Yahoo Finance Live anchor Josh Lipton looks ahead to the earnings results due out from Apple (AAPL), Eli Lilly (LLY), and Paramount (PARA). He also previews Yahoo Finance Executive Editor …
Another experimental Alzheimer’s drug, donanemab, has been found to modestly slow the progression of the disease in patients by about four to seven months, according to researchers. Eli Lilly and …